Hengxin Life Science and Technology

Hengxin Life Science and Technology is a biotechnology company based in Beijing, China, specializing in the research, storage, and clinical application of immune and stem cells. The company focuses on the development of innovative cell therapies, particularly Natural Killer (NK) cell-based immunotherapies for the treatment of solid tumors and regenerative medicine. In addition to its therapeutic pipeline, Hengxin operates a large-scale cell bank providing cryopreservation services for autologous immune cells and mesenchymal stem cells. By integrating clinical research with standardized cell processing technology, the company aims to provide personalized medical solutions for cancer treatment and healthy aging.